From everything that I have read . I think Castle is a speculative buy at best . It has traded in this range for years . I like the Management Team and the product line . I think there is more upside then there is down side . I would suggest to everone to do there home work on Castle .
BASHERS are watching you!!! You could lose your job, as a PAID-BASHER!!! SO BEWARE!!
IMHO today's release isn't being read properly. This is great news from the standpoint of milestone achievement. They needed money, they got it in a hurry, and now they move on based on clinical data, rather than economic maneuvering. The only financial necessity for small pharma is to stay afloat. From there the drug(s) either works or doesn't. I'll give you that it matters to those who are knickel and diming the stock but not for those looking for more based on DD of the clinicals. Nobody will be complaining of dilution if this thing hits its potential. So hang in there if you think the drug is worthwhile, jump out if you think its not.
Isn't this like saying there are more fans of WWE every day so THQ was undervalued?
Men and women these people happen to be right with their last recommendations, please make sure to read their next newsletter so you fully grasp the up coming alert thouroughly.
This looks very much like a scam. The acquiring company did not exist until recently, an asset search turns up nothing, their web site is actually an edited free template, with no links. No evidence exists of the presence of the company in the cities listed on their site. When the SEC disclosure is made public I strongly suspect that the deal will involve almost no money. Contrary to the release the bluescience products have not been even remotely successful. Looks like an attempt to make the abandonment of the line look like a legitimate deal. This is what is known in the trade as Polishing a T E R D.